{
    "id": "58488908",
    "text": "Estradiol benzoate/hydroxyprogesterone caproate (EB/OHPC), sold under the brand name Primosiston among others, is a combined estrogen and progestogen medication which is used to treat gynecological disorders and habitual abortion. It contains estradiol benzoate (EB), an estrogen, and hydroxyprogesterone caproate (OHPC), a progestin. The medication is given by injection into muscle. ==Medical uses== EB/OHPC is used in the treatment of gynecological disorders such as menstrual disorders (e.g., amenorrhea, dysfunctional uterine bleeding) and premenstrual syndrome, habitual abortion (threatened miscarriage), and for other indications. ===Available forms=== EB/OHPC is available in the form of ampoules of oil solutions containing 10 mg estradiol benzoate (EB) and 125 to 250 mg hydroxyprogesterone caproate (OHPC). ==History== EB/OHPC was first introduced for medical use in 1955. ==Society and culture== ===Brand names=== EB/OHPC has been marketed under brand names including Dos Dias N, Lutes, Ostrolut, Primosiston (or Primosiston Inj. / Injection), Primosiston Fuerte, and Syngynon. ===Availability=== EB/OHPC has been mostly discontinued and hence is mostly no longer available. It remains marketed under the brand names Primosiston in Ecuador and Peru, Dos Dias N in Argentina, and Lutes in Japan. It was previously marketed under the brand names Ostrolut in Austria; Primosiston (or Primosiston Inj. / Injection) (Schering) in Argentina, Germany, Mexico, Switzerland, and Venezuela; Primosiston Fuerte in Spain; and Syngynon in Germany, but these formulations have all been discontinued and hence are no longer available in these countries. ==See also== * Estradiol dipropionate/hydroxyprogesterone caproate * Estradiol valerate/hydroxyprogesterone caproate * Estradiol benzoate/progesterone * List of combined sex-hormonal preparations ==References== Category:Combined estrogen\u2013progestogen formulations ",
    "title": "Estradiol benzoate/hydroxyprogesterone caproate"
}